Kelly Wilson
Chief Operating Officer at BIOSTAX CORP.
Net worth: 733 599 $ as of 29/04/2024
Profile
Kelly O’Brien Wilson currently works at Forte Animal Health, Inc., as Director from 2020 and Biostax Corp., as Chief Operating Officer from 2022.
Ms. Wilson also formerly worked at Biostax Corp., as CTO & Director-Human Resources from 2015 to 2020, Biostax Corp., as Chief Executive & Operating Officer in 2023, and Cytocom, Inc., as Chief Technology & Information Officer from 2016 to 2020.
Ms. Wilson received her undergraduate degree and graduate degree from the University of Central Florida.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
BIOSTAX CORP
18.64% | 27/03/2024 | 15,608,498 ( 18.64% ) | 733 599 $ | 29/04/2024 |
Kelly Wilson active positions
Companies | Position | Start |
---|---|---|
BIOSTAX CORP. | Chief Operating Officer | 31/07/2022 |
Forte Animal Health, Inc. | Director/Board Member | 30/11/2020 |
Former positions of Kelly Wilson
Companies | Position | End |
---|---|---|
BIOSTAX CORP. | Chief Executive Officer | 24/07/2023 |
BIOSTAX CORP. | Chief Tech/Sci/R&D Officer | 31/03/2020 |
Cytocom, Inc. /Old/
Cytocom, Inc. /Old/ BiotechnologyHealth Technology Cytocom, Inc. operates as biotech company which specializes in repurposing of drugs that deploys patented therapies and develops novel immune therapies. The company was founded by Noreen M. Griffin and is headquartered in Winter Park, FL. | Chief Tech/Sci/R&D Officer | 31/03/2020 |
Training of Kelly Wilson
University of Central Florida | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BIOSTAX CORP. | Health Technology |
Private companies | 2 |
---|---|
Cytocom, Inc. /Old/
Cytocom, Inc. /Old/ BiotechnologyHealth Technology Cytocom, Inc. operates as biotech company which specializes in repurposing of drugs that deploys patented therapies and develops novel immune therapies. The company was founded by Noreen M. Griffin and is headquartered in Winter Park, FL. | Health Technology |
Forte Animal Health, Inc. |
- Stock Market
- Insiders
- Kelly Wilson